Radiobotics has received the FDA’s 510(k) clearance for its RBknee artificial intelligence-based analysis tool designed to improve the accuracy of radiographic knee osteoarthritis diagnosis.

RBknee is intended for use in an orthopedic or a radiological setting, the Copenhagen-based company says.

The tool analyzes digital x-rays of knees and identifies common radiographic findings associated with osteoarthritis, using machine-learning algorithms to identify sclerosis and the narrowing of joint space in the knee.